Revenue: The sum of all revenue fields included for a company's operating activities.
Amicus Therapeutics, Inc. (FOLD) had Revenue of $115.08M for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
$115.08M |
$-33.84M |
|
$11.32M |
|
$103.76M |
|
$118.77M |
|
$-3.69M |
|
$-27.97M |
|
$-31.66M |
|
$-31.66M |
|
$-33.84M |
|
$-33.84M |
|
$-33.84M |
|
$-33.84M |
|
$-3.69M |
|
$-0.97M |
|
295.16M |
|
295.16M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$483.06M |
|
$31.67M |
|
$294.82M |
|
$777.88M |
|
$167.69M |
|
$387.86M |
|
$450.02M |
|
$617.71M |
|
$160.17M |
|
$-58.11M |
|
$160.17M |
|
293.59M |
|
| Cash Flow Statement Financials | |
$-69.09M |
|
$98.06M |
|
$61.68M |
|
$153.12M |
|
$250.08M |
|
$96.96M |
|
$86.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.88 |
|
-- |
|
-- |
|
0.71 |
|
2.42 |
|
90.16% |
|
-3.21% |
|
-3.21% |
|
-- |
|
-27.51% |
|
-29.41% |
|
$-76.53M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
0.19 |
|
1.31 |
|
68.53 |
|
-21.13% |
|
58.24% |
|
-4.35% |
|
-6.18% |
|
$0.55 |
|
$-0.26 |
|
$-0.23 |
|